DOK1
Reactivity: Human
WB
Host: Mouse
Polyclonal
unconjugated
Application Notes
WB: 0.2-1 µg/mL Optimal conditions should be determined by the investigator.
Restrictions
For Research Use only
Format
Lyophilized
Concentration
Lot specific
Buffer
Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
Handling Advice
Avoid repeated freeze/thaw cycles.
Storage
4 °C/-20 °C
Storage Comment
Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
Target
DOK1
(Docking Protein 1, 62kDa (Downstream of tyrosine Kinase 1) (DOK1))
Alternative Name
DOK1
Background
DOK1 is constitutively tyrosine phosphorylated in hematopoietic progenitors isolated from chronic myelogenous leukemia (CML) patients in the chronic phase. It may be a critical substrate for p210(bcr/abl), a chimeric protein whose presence is associated with CML. DOK1 contains a putative pleckstrin homology domain at the amino terminus and ten PXXP SH3 recognition motifs. Docking protein 2 binds p120 (RasGAP) from CML cells. It has been postulated to play a role in mitogenic signaling. Synonyms: Polyclonal DOK1 antibody, Anti-DOK1 antibody, docking protein 1, 62kDa, downstream of tyrosine kinase 1 antibody, MGC117395 antibody, MGC138860 antibody, P62DOK antibody.